tirzepatide vs metformin for weight loss Outperforms in T2D Treatment Metformin + Tirzepatide for Weight

In this model, scheduled visits from weeks 4208 (that is, including the additional laboratory data collection visits for European patients) for the full analysis set were included as fixed effects, and interactions with treatment and baseline allowed the treatment effect and the importance of the baseline to vary over visits

Patients should contact their provider if they experience signs of hypoglycemia (confusion, sweating, tremor, rapid heartbeat), particularly if taking tirzepatide concurrently with insulin or sulfonylureas, as dose adjustments of these medications may be necessary

Nevertheless, Garg is making very conservative recommendations and has repeatedly advised that patients try to taper off and discontinue their GLP-1 after reaching their weight loss goal

Folpe AL, Hameed M